Envista Holdings (NVST) Shares Outstanding (Weighted Average) (2017 - 2026)
Envista Holdings' quarterly Shares Outstanding (Weighted Average) came in at $163.9 million in Q2 2026, down 4.93% year-on-year from $172.4 million in Q2 2025, and down 2.44% quarter-over-quarter from $168.0 million in Q4 2025.
Envista Holdings has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $163.9 million in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Weighted Average) fell 4.93% year-over-year to $163.9 million; the trailing twelve-month figure through Apr 2026 stood at $163.9 million (down 4.93% YoY), and the FY2025 full-year result was $168.0 million, down 2.44% from the prior year.
- Shares Outstanding (Weighted Average) for Q2 2026 stood at $163.9 million, down from $168.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $172.4 million in Q1 2025, with the low at $162.2 million in Q2 2022.
- Average Shares Outstanding (Weighted Average) over 5 years is $167.2 million, with a median of $166.9 million recorded in 2023.
- Year-over-year, Shares Outstanding (Weighted Average) advanced 5.07% in 2024 and decreased 4.93% in 2026.
- Tracing NVST's Shares Outstanding (Weighted Average) over 5 years: stood at $162.9 million in 2022, then increased by 2.46% to $166.9 million in 2023, then climbed by 3.18% to $172.2 million in 2024, then fell by 2.44% to $168.0 million in 2025, then declined by 2.44% to $163.9 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $163.9 million (Q2 2026), $168.0 million (Q4 2025), and $169.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 354.90 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 283.14 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.34 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.00 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 174.20 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 195.80 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.43 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.05 Mn |
| 10 | Envista Holdings | 3.87 Bn | 2.79 Bn | 390.10 Mn | 163.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 163.90 Mn |
| Dec 31, 2025 | 168.00 Mn |
| Sep 26, 2025 | 169.20 Mn |
| Jun 27, 2025 | 170.70 Mn |
| Mar 28, 2025 | 172.40 Mn |
| Dec 31, 2024 | 172.20 Mn |
| Sep 27, 2024 | 172.20 Mn |
| Jun 28, 2024 | 172.00 Mn |
| Mar 29, 2024 | 171.90 Mn |
| Dec 31, 2023 | 166.90 Mn |
| Sep 29, 2023 | 165.30 Mn |
| Jun 30, 2023 | 164.00 Mn |
| Mar 31, 2023 | 163.60 Mn |
| Dec 31, 2022 | 162.90 Mn |
| Sep 30, 2022 | 162.70 Mn |
| Jul 1, 2022 | 162.60 Mn |
| Apr 1, 2022 | 162.20 Mn |
| Dec 31, 2021 | 161.20 Mn |
| Oct 1, 2021 | 161.50 Mn |
| Jul 2, 2021 | 161.20 Mn |
| Apr 2, 2021 | 160.50 Mn |
| Dec 31, 2020 | 159.60 Mn |
| Oct 2, 2020 | 159.70 Mn |
| Jul 3, 2020 | 159.50 Mn |
| Apr 3, 2020 | 159.20 Mn |
| Dec 31, 2019 | 136.20 Mn |
| Sep 27, 2019 | 130.60 Mn |
| Jun 28, 2019 | 127.90 Mn |
| Mar 29, 2019 | 127.90 Mn |
| Dec 31, 2018 | 127.90 Mn |
| Sep 28, 2018 | 127.90 Mn |
| Dec 31, 2017 | 127.90 Mn |